Kawai A

ORCID: 0009-0004-5900-1144 · 1 paper in corpus

2026

Linzagolix versus leuprorelin in Japanese women with uterine leiomyomas: a phase 3, randomized, active-controlled, non-inferiority trial.

Human reproduction (Oxford, England) ·doi:10.1093/humrep/deag106

Study questionHow does the efficacy of linzagolix (a gonadotropin-releasing hormone [GnRH] receptor antagonist) compare with leuprorelin (a GnRH agonist) for the treatment of heavy menstrual bleeding (HMB) in patients with uterine leiomyoma…